HOCM

  • From the Morrow operation of the 60´s to current techniques. 

Heart Transplantation and artificial assistance devices

  • Why do Spain, Croatia and USA have so many organ donors?
  • Changes in the postoperative management of HTX

Innovation is an easy word but, who is really pushing?

  • Motivating the trainees on research is essential
  • Any mission for the undergraduates in the University or College?
  • Scientific societies: what are they doing in practice?
  • The model of departmental organization and its implications
  • Engineers are becoming a frequent partner in Cardiovascular field
  • Is MIS still innovative or already a routine?
  • The 2023 robotics in CTS: Last innovations after more than 25 years?
  • The crucial role of industry in CTS and its complex (?) partnership.

Education in Cardiothoracic Surgery

  • The cost of training a CT Surgeon world wide:
    • In USA and Australia
    • In Europe
    • In Middle East and Asia
    • Peculiarities of China training
    • In Africa: Differences from North and South
  • An approach to best worldwide teaching programs
  • Why do some countries have so few candidates?
  • Migration of professionals: some pay a lot for others benefit?
  • Towards a new paradigm?
  • A common trunk in
    • Cardiovascular Medicine
    • Pulmonology Medicine
  • Simulation in cardiac surgery and CPB

HOCM

Join us in Barcelona between 5-6 September 2024 for the 1st Barcelona Symposium for the management of obstructive hypertrophic cardiomyopathy – a meeting that will navigate new horizons in medical and surgical management of HOCM to improve patient outcomes. 

This is a dedicated meeting for HOCM management that will count on the presence of a distinguished international faculty. During the meeting you can expect enhanced interaction amongst cardiologists and cardiovascular surgeons with focused interest in this disease. Key opinion leaders in this field will provide the most updated evidence and experiences to tailor therapeutic strategies for this complex and varied patient population.

Never before treatment options for symptomatic obstruction had been so diverse. We are in a historical moment. Both, medical and surgical fields are advancing at great speed. It is now, more than ever, imperative to exchange knowledge on each therapeutic option so that the best shared decision-making is offered to our patients. 

The meeting will cover from the expansion into daily clinical practice of myosin inhibitors to the most contemporary minimally invasive surgical options. We will provide a deep dive into pre-intervention imaging, selection of treatments, establishment/monitoring of advanced medical treatment, techniques for the classic gold standard transaortic septal myectomy, minimal access alternative options including robotics, and the least invasive novel transapical beating heart septal myectomy (TA-BSM). 

Beyond key lectures and discussions of relevant medical and operative topics we will offer live-in-a-box experiences for the management of challenging clinical situations that may be encountered in clinical practice. 

The meeting also seeks to expand the interaction amongst teams that have already consolidated HOCM practices and invites the participation of new groups that are striving to achieve excellence in the management of such patients.